In New Hampshire, pet owners face a frustrating reality: our dogs and cats must receive repeated rabies booster shots every ...

The New Hampshire House of Representatives is considering a bill that would exempt some pets from booster shots intended to ...

Q4 2025 Earnings Call February 25, 2026 4:30 PM ESTCompany ParticipantsAdam Grossman - Co-Founder, President, CEO ...

NorthX Biologics and Demeetra today announced a strategic collaboration combining a best-in-class high-titer GS (-/-) CHO cell line with full freedom to operate and no additional IP-related costs, ...

STgen Bio announced Thursday that it will expand its first plant to meet rising demand for high-titer biopharmaceuticals. This capacity boost involves adding mi ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...

ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...

NorthX Biologics and Demeetra are collaborating to help biotech companies reach Investigational New Drug and clinical ...

Brad Tade, CFO & Treasurer, stated, "Our full year 2025 financial results demonstrate ADMA's consistent execution, expanding profitability and earnings power." Tade reported fourth quarter revenue of ...

Hørsholm, Denmark, 19 February 2026 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its full-year and fourth quarter 2025 results. The report is available as an attachment and on ExpreS ...

(Bloomberg) --The three-month slump in US technology stocks has left long-downtrodden value stocks looking relatively strong. There’s growing consensus on Wall Street the shift is just getting started ...